Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec;69(12):2265-2267.
doi: 10.1136/gutjnl-2020-321052. Epub 2020 Apr 9.

Proton pump inhibitors and the risk of gallbladder cancer: a hospital-based case-control study

Jianping Xiong  1 , Yaqin Wang  2 , Guang Chen  1 , Long Jin  3
Affiliations
Comment

Proton pump inhibitors and the risk of gallbladder cancer: a hospital-based case-control study

Jianping Xiong et al. Gut. 2020 Dec.
No abstract available

Keywords: gallbladder cancer; proton pump inhibition.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment on

References

    1. Chuang S-C, Lin C-C, Peng C-Y, et al. Proton pump inhibitors increase the risk of cholecystitis: a population-based case-control study. Gut 2019;68:1337–9. 10.1136/gutjnl-2018-316899 - DOI - PubMed
    1. Haastrup P, Paulsen MS, Zwisler JE, et al. Rapidly increasing prescribing of proton pump inhibitors in primary care despite interventions: a nationwide observational study. Eur J Gen Pract 2014;20:290–3. 10.3109/13814788.2014.905535 - DOI - PubMed
    1. Kahrilas PJ. Clinical practice. Gastroesophageal reflux disease. N Engl J Med 2008;359:1700–7. 10.1056/NEJMcp0804684 - DOI - PMC - PubMed
    1. Malfertheiner P, Chan FKL, McColl KEL. Peptic ulcer disease. Lancet 2009;374:1449–61. 10.1016/S0140-6736(09)60938-7 - DOI - PubMed
    1. Li L, Geraghty OC, Mehta Z, et al. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study. Lancet 2017;390:490–9. 10.1016/S0140-6736(17)30770-5 - DOI - PMC - PubMed

Substances